Top Quality Dasatinib Monohydrate CAS 863127-77-9

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP
• Suitable for: Adult
• State: Solid
• Purity: >99%
• Model NO.: TGY-dasatinib
• Product Name: Dasatinib
• CAS: 863127-77-9
• Delivery: EMS TNT
• Shelf Life: 24 Months
• Sample: 10g
• Test Method: HPLC
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: TGY
• Origin: China
• HS Code: 2200
• Production Capacity: 50000 Kg Per Month More

Product Description

 

Product Name: Dasatinib Monohydrate

Form: Powder

Purity: 99%

MF: C22H28ClN7O3S

CAS No.: 863127-77-9

Brand: Salus

COA: Available

Sample: Available

Shelf Life: 2 Years

Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cance

 

Specification:

Item	Specification
Appearance	White Powder
Assay(HPLC)	≥99%
Solutility	Insoluble in water and slightly soluble in ethanol and meth
Identification a)1H-NMR b)Retention time(HPLC)	Conforms to standard Conforms to standard
Melting point	275.0-286.0°C
Water Content(KF)	2.8-4.2%
Residue on ignition	≤0.2%
Heavy metals	≤20ppm
Related substances Any single impurities Total impurities	≤0.5% ≤1.0%

Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.